Efficacy of Prazosin Versus Placebo Associated With Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis

NCT00148837 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

112

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hepatitis C, Chronic
Fibrosis

Interventions

DRUG: Peg-interferon alpha 2b (drug)
DRUG: Ribavirin (drug)
DRUG: Prazosin (drug)

Sponsor

French National Agency for Research on AIDS and Viral Hepatitis